Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells

Acta Biochimica et Biophysica Sinica

Volumn 47, Issue 5, 2015, Pages 368-375

  Li, Shuangshuang ^a,b   Gao, Xiangli ^a   Wu, Xiaoxin ^c   Wu, Zhigang ^c   Cheng, Linfang ^c   Zhu, Lifen ^a   Shen, Dan ^a   Tong, Xiangmin ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

anti inflammation; inflammatory cytokine; MAPK; parthenolide; TLR4

Indexed keywords

AUTACOID; CYTOKINE; LIPOPOLYSACCHARIDE; PARTHENOLIDE; SESQUITERPENE; TOLL LIKE RECEPTOR 4;

CELL LINE; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

CELL LINE; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; SESQUITERPENES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84944273170     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmv019     Document Type: Article

References (38)

1. Fukata M, Arditi M. The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol 2013, 6: 451-463.
2. Heidegger S, van den Brink MR, Haas T, Poeck H. The role of patternrecognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation. Front Immunol 2014, 5: 337.
3. Zhang X, Wang G, Gurley EC, Zhou H. Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages. PLoS One 2014, 9: e107072.
4. Plociennikowska A, Hromada-Judycka A, Borzecka K, Kwiatkowska K. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 2015, 72: 557-581.
5. Rich AM, Hussaini HM, Parachuru VP, Seymour GJ. Toll-like receptors and cancer, particularly oral squamous cell carcinoma. Front Immunol 2014, 5: 464.
6. Risitano R, Curro M, Cirmi S, Ferlazzo N, Campiglia P, Caccamo D, Ientile R, et al. Flavonoid fraction of bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-kappaB inhibition in THP-1 monocytes. PLoS One 2014, 9: e107431.
7. Wu F, Zhang W, Li L, Zheng F, Shao X, Zhou J, Li H. Inhibitory effects of honokiol on lipopolysaccharide-induced cellular responses and signaling events in human renal mesangial cells. Eur J Pharmacol 2011, 654: 117-121.
8. Bork PM, Schmitz ML, Kuhnt M, Escher C, Heinrich M. Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB. FEBS Lett 1997, 402: 85-90.
9. Fukuda K, Hibiya Y, Mutoh M, Ohno Y, Yamashita K, Akao S, Fujiwara H. Inhibition by parthenolide of phorbol ester-induced transcriptional activation of inducible nitric oxide synthase gene in a human monocyte cell line THP-1. Biochem Pharmacol 2000, 60: 595-600.
10. Xie H,Wang C, Wu X, Liu X, Qiao S, Liu C, Liu H. Parthenolide attenuates LPS-induced activation of NF-kappaB in a time-dependent manner in rat myocardium. J Biomed Res 2012, 26: 37-43.
11. Magni P, Ruscica M, Dozio E, Rizzi E, Beretta G, Maffei FR. Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-alpha and NF-kappaB nuclear translocation in BV-2 microglia. Phytother Res 2012, 26: 1405-1409.
12. Fiebich BL, Lieb K, Engels S, Heinrich M. Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J Neuroimmunol 2002, 132: 18-24.
13. Park SJ, Shin HJ, Youn HS. Parthenolide inhibits TRIF-dependent signaling pathway of toll-like receptors in RAW264.7 macrophages. Mol Cells 2011, 31: 261-265.
14. Wang T, Dai Y, Dun Y, Zhang C, Wan J, Deng L, Zhou Z, et al. Chikusetsusaponin V inhibits inflammatory responses via NF-kappaB and MAPK signaling pathways in LPS-induced RAW 264.7 macrophages. Immunopharmacol Immunotoxicol 2014, 0: 1-8.
15. Malavez Y, Voss OH, Gonzalez-Mejia ME, Parihar A, Doseff AI. Distinct contribution of PKCdelta and PKCepsilon in the lifespan and immune response of human blood monocyte subpopulations. Immunology 2015, 144: 611-620.
16. Zhong Y, Lin Y, Shen S, Zhou Y, Mao F, Guan J, Sun Q. Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse. Cancer Cell Int 2013, 13: 60.
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25: 402-408.
18. Prince LS, Okoh VO, Moninger TO, Matalon S. Lipopolysaccharide increases alveolar type II cell number in fetal mouse lungs through toll-like receptor 4 and NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2004, 287: L999-L1006.
19. Zhao W, Ma G, Chen X. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-kappaB pathway. Vascul Pharmacol 2014, 63: 162-172.
20. Hosek J, Novotna R, Babula P, Vanco J, Travnicek Z. Zn(II)-chlorido complexes of phytohormone kinetin and its derivatives modulate expression of inflammatory mediators in THP-1 cells. PLoS One 2013, 8: e65214.
21. Moon SJ, Park MK, Oh HJ, Lee SY, Kwok SK, Cho ML, Ju JH, et al. Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts. Korean J Intern Med 2010, 25: 429-435.
22. Jung YO, Cho ML, Kang CM, Jhun JY, Park JS, Oh HJ, Min JK, et al. Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts. Immunol Lett 2007, 109: 21-27.
23. Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM. The antiinflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem Biol 2001, 8: 759-766.
24. Quan J, Liu J, Gao X, Liu J, Yang H, ChenW, LiW, et al. Palmitate induces interleukin-8 expression in human aortic vascular smooth muscle cells via toll-like receptor 4/nuclear factor-kappaB pathway (TLR4/NF-kappaB-8). J Diabetes 2014, 6: 33-41.
25. Kang BY, Chung SW, Kim TS. Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by parthenolide, a predominant sesquiterpene lactone in Tanacetum parthenium: involvement of nuclear factor-kappaB. Immunol Lett 2001, 77: 159-163.
26. Cho YC, Lee SH, Lee M, Kim HJ, Oak MH, Lee IS, Kang BY. Enhanced IL-12p40 production in LPS-stimulated macrophages by inhibiting JNK activation by artemisinin. Arch Pharm Res 2012, 35: 1961-1968.
27. Olafsdottir A, Thorlacius GE, Omarsdottir S, Olafsdottir ES, Vikingsson A, Freysdottir J, Hardardottir I. A heteroglycan from the cyanobacterium Nostoc commune modulates LPS-induced inflammatory cytokine secretion by THP-1 monocytes through phosphorylation of ERK1/2 and Akt. Phytomedicine 2014, 21: 1451-1457.
28. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005, 17: 1-14.
29. PangHY, Liu G, Liu GT. Compound FLZ inhibits lipopolysaccharide-induced inflammatory effects via down-regulation of the TAK-IKK and TAK-JNK/ p38MAPK pathways in RAW264.7 macrophages. Acta Pharmacol Sin 2009, 30: 209-218.
30. Madhavan S, Anghelina M, Sjostrom D, Dossumbekova A, Guttridge DC, Agarwal S. Biomechanical signals suppress TAK1 activation to inhibit NF-kappaB transcriptional activation in fibrochondrocytes. J Immunol 2007, 179: 6246-6254.
31. Chun J, Choi RJ, Khan S, Lee DS, Kim YC, Nam YJ, Lee DU, et al. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-kappaB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells. Int Immunopharmacol 2012, 14: 375-383.
32. Maletzki C, Emmrich J. Inflammation and immunity in the tumor environment. Digest Dis 2010, 28: 574-578.
33. Morgenstern DA, Anderson J. Inflammation: what role in pediatric cancer? Pediatr Blood Cancer 2012, 58: 659-664.
34. Kreuger MR, Grootjans S, Biavatti MW, Vandenabeele P, D'Herde K. Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide. Anticancer Drugs 2012, 23: 883-896.
35. Reikvam H, Olsnes AM, Gjertsen BT, Ersvar E, Bruserud O. Nuclear factor-kappaB signaling: a contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia. Crit Rev Oncog 2009, 15: 1-41.
36. Guzman ML. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 2005, 105: 4163-4169.
37. WuW, Jia Y, Du S, Tang H, Sun Y, Sun L. Changes of sulfur dioxide, nuclear factor-kappaB, and interleukin-8 levels in pediatric acute lymphoblastic leukemia with bacterial inflammation. Chin Med J 2014, 127: 4110-4113.
38. Steele AJ, Jones DT, Ganeshaguru K, Duke VM, Yogashangary BC, North JM, Lowdell MW, et al. The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia 2006, 20: 1073-1079.